Cargando…
Impact of body mass index on the outcome of Japanese patients with cardiovascular diseases and/or risk factors hospitalized with COVID-19 infection
BACKGROUND: Obesity is reported to be a predictor of adverse clinical events in coronavirus disease 2019 (COVID-19) in Western countries. However, there are limited data reported regarding the prognostic impact of obesity in Asian patients. We investigated the relationship between body mass index (B...
Autores principales: | Saito, Takafumi, Yamaguchi, Tetsuo, Kuroda, Shunsuke, Kitai, Takeshi, Yonetsu, Taishi, Kohsaka, Shun, Torii, Sho, Node, Koichi, Matsumoto, Shingo, Matsue, Yuya, Kodama, Takahide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese College of Cardiology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479451/ https://www.ncbi.nlm.nih.gov/pubmed/34625315 http://dx.doi.org/10.1016/j.jjcc.2021.09.013 |
Ejemplares similares
-
Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry()
por: Shibahashi, Eiji, et al.
Publicado: (2022) -
Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors
por: Higaki, Akinori, et al.
Publicado: (2022) -
External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factors
por: Kuroda, Shunsuke, et al.
Publicado: (2021) -
Sex Differences in Clinical Outcomes Among Patients With COVID-19 and Cardiovascular Disease ― Insights From the CLAVIS-COVID Registry ―
por: Matsumoto, Shingo, et al.
Publicado: (2022) -
Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients
por: Kitakata, Hiroki, et al.
Publicado: (2021)